Noradrenergic inhibition and alpha 2-adrenergic stimulation of melatonin secretion in the pigeon

J Neurochem. 1992 Sep;59(3):915-8. doi: 10.1111/j.1471-4159.1992.tb08330.x.

Abstract

Adrenergic regulatory mechanisms of melatonin synthesis and secretion were studied in the pigeon in vivo. Late-afternoon intraperitoneal injection of noradrenaline (NA; 1 mg/kg) resulted in a significant decrease in plasma melatonin levels in 3 h. The same effect was seen after phenylephrine treatment (1 mg/kg i.p.), indicating that an alpha 1-adrenergic mechanism may mediate the inhibition. Propranolol treatment had no effect on plasma melatonin levels, supporting this concept. Detomidine (1 mg/kg i.p.), an alpha 2-adrenergic agonist, increased melatonin levels. This stimulatory effect was blocked by yohimbine, an alpha 2-adrenergic antagonist. However, yohimbine alone had no effect on the plasma melatonin levels, suggesting that alpha 2-adrenergic transmission is not primarily responsible for the nocturnal stimulation of melatonin synthesis and secretion in the pigeon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Circadian Rhythm
  • Columbidae
  • Imidazoles / pharmacology
  • Melatonin / antagonists & inhibitors*
  • Melatonin / blood
  • Melatonin / metabolism
  • Norepinephrine / pharmacology*
  • Receptors, Adrenergic, alpha / physiology*
  • Sympathomimetics / pharmacology
  • Time Factors

Substances

  • Imidazoles
  • Receptors, Adrenergic, alpha
  • Sympathomimetics
  • detomidine
  • Melatonin
  • Norepinephrine